<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">PONE-D-12-39893</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0060607</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Human genetics</subject>
              <subj-group>
                <subject>Genetic association studies</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Population genetics</subject>
              <subj-group>
                <subject>Genetic polymorphism</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Cancer genetics</subject>
              <subject>Genome-wide association studies</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Population biology</subject>
            <subj-group>
              <subject>Population genetics</subject>
              <subj-group>
                <subject>Genetic polymorphism</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Gastroenterology and hepatology</subject>
            <subj-group>
              <subject>Gastrointestinal cancers</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Oncology</subject>
            <subj-group>
              <subject>Cancer risk factors</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Genetics and Genomics</subject>
          <subject>Oncology</subject>
          <subject>Gastroenterology and Hepatology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Quantitative Assessment of the Effect of Cytochrome P450 2C9 Gene Polymorphism and Colorectal Cancer</article-title>
        <alt-title alt-title-type="running-head">Colorectal Cancer Genetics</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
          <name name-style="western">
            <surname>Zhao</surname>
            <given-names>Yuan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
          <name name-style="western">
            <surname>Han</surname>
            <given-names>Yusong</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Zhang</surname>
            <given-names>Liang</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Yichao</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Ma</surname>
            <given-names>Yushui</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Zhang</surname>
            <given-names>Feng</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Fu</surname>
            <given-names>Da</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Xiaofeng</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic China</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic China</addr-line>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <addr-line>Department of Orthopaedics Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic China</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Xiong</surname>
            <given-names>Momiao</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>University of Texas School of Public Health, United States of America</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">superdafu@hotmail.com</email> (DF); <email xlink:type="simple">superwangxf@hotmail.com</email> (XFW)</corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: DF XFW. Performed the experiments: YZ YSH LZ YCW YSM FZ. Analyzed the data: YZ YSH DF XFW. Contributed reagents/materials/analysis tools: YZ YSH LZ YCW YSM FZ. Wrote the paper: DF XFW.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>4</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <issue>4</issue>
      <elocation-id>e60607</elocation-id>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Zhao et al</copyright-holder>
        <license xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>CYP2C9 enzyme activity is involved in the metabolism of substances related to colorectal cancer (CRC), and it is functionally linked to a genetic polymorphism. Two allelic variants of the <italic>CYP2C9</italic> gene, namely <italic>CYP2C9</italic>*2 and <italic>CYP2C9</italic>*3, differ from wild-type <italic>CYP2C9</italic>*1 by single amino acid substitutions. These mutated alleles encode enzymes with altered properties that are associated with impaired metabolism. In the past decade, a number of case-control studies have been carried out to investigate the relationship between the <italic>CYP2C9</italic> polymorphism and CRC susceptibility, but the results were conflicting. To investigate this inconsistency, we performed a meta-analysis of 13 studies involving a total of 20,879 subjects for <italic>CYP2C9</italic>*2 and *3 polymorphisms to evaluate the effect of <italic>CYP2C9</italic> on genetic susceptibility for CRC. Overall, the summary odds ratio of CRC was 0.94 (95%CI: 0.87–1.03, P = 0.18) and 1.00 (95%CI: 0.86–1.16, P = 0.99) for <italic>CYP2C9</italic> *2 and *3 carriers, respectively. No significant results were observed in heterozygous and homozygous when compared with wild genotype for these polymorphisms. In the stratified analyses according to ethnicity, sample size, diagnostic criterion, HWE status and sex, no evidence of any gene-disease association was obtained. Our result suggest that the *2, *3 polymorphisms of <italic>CYP2C9</italic> gene are not associated with CRC susceptibility.</p>
      </abstract>
      <funding-group>
        <funding-statement>This work was supported by China Postdoctoral Science Foundation Funded Project (20100480542, 201104227), National Natural Science Foundation of China (81201535), Nature Science Foundation of Shanghai (12ZR1436000), Youth Innovation Promotion Association and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="8"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Colorectal cancer (CRC) is the third most common type of cancer in the western world and is responsible for approximately 50,000 deaths per year <xref ref-type="bibr" rid="pone.0060607-Jemal1">[1]</xref>. Family-based studies have suggested that the disease has a significant genetic component, with a large twin study conducted in Scandinavian countries suggesting that as many as 35% of colorectal cancers may be due to inherited susceptibility <xref ref-type="bibr" rid="pone.0060607-Lichtenstein1">[2]</xref>. However, the recognized Mendelian predisposition syndromes, such as hereditary nonpolyposis colorectal cancer and adenomatus polyposis coli, account for less than 5% of the overall incidence of colorectal cancer <xref ref-type="bibr" rid="pone.0060607-Calvert1">[3]</xref>. Therefore, common, low-penetrance polymorphisms may confer a substantial part of the genetic risk, but given that the estimated effect of each polymorphism is expected to be small, large studies are necessary to reduce the size-related uncertainty of effects and provide robust evidence of association.</p>
      <p>Specific components of the western diet including meat consumption (particularly red and/or well-done meat) and dietary fat (particularly polyunsaturated fatty acids) have been proposed as risk factors which influence susceptibility to colorectal cancer <xref ref-type="bibr" rid="pone.0060607-Bartsch1">[4]</xref>–<xref ref-type="bibr" rid="pone.0060607-deVerdier1">[5]</xref>. It has been suggested that this may be due to carcinogenic polycyclic aromatic hydrocarbons (PAH) and heterocyclic amines (HCA) produced when meat is cooked at high temperatures. Data from both in vitro and in vivo studies suggest that exposure to PAH significantly increase colorectal cancer risk <xref ref-type="bibr" rid="pone.0060607-Nagao1">[6]</xref>, <xref ref-type="bibr" rid="pone.0060607-Sugimura1">[7]</xref>. Cytochrome P450 2C9 (CYP2C9) is a key P450 enzyme which plays an important role in the metabolism and bioactivation of many dietary and environmental mutagens <xref ref-type="bibr" rid="pone.0060607-Schwarz1">[8]</xref>. A variety of studies have demonstrated that the metabolism of PAH and other procarcinogens through CYP2C9 may well lead to the activation of the carcinogenic compounds <xref ref-type="bibr" rid="pone.0060607-Gooderham1">[9]</xref>, <xref ref-type="bibr" rid="pone.0060607-Oda1">[10]</xref>. CYP2C9 enzyme activity in man is modulated by genetic polymorphisms. The variant alleles <italic>CYP2C9</italic>*2 (R144C) and *3 (I359L) produce slow-metabolizing enzymes compared with wild-type <italic>CYP2C9</italic>*1 <xref ref-type="bibr" rid="pone.0060607-SullivanKlose1">[11]</xref>, <xref ref-type="bibr" rid="pone.0060607-Gill1">[12]</xref>. Hence, <italic>CYP2C9</italic> gene may be a good candidate for genetics studies on CRC.</p>
      <p>Over the past few years, considerable efforts have been devoted to exploring the relationships between the <italic>CYP2C9</italic> polymorphisms and CRC risk among various populations. But the results are not always consistent. There are several possible explanations for this discordance, such as small sample size, ethnic background, uncorrected multiple hypothesis testing, and publication bias. Meta-analysis is a statistical procedure for combining the results of several studies to produce a single estimate of the major effect with enhanced precision. It has become important in cancer genetics because of rapid increases in the number and size of datasets. The aim of the present study is to perform a comprehensive meta-analysis to evaluate the association between the <italic>CYP2C9</italic> *2 and *3 polymorphism and CRC.</p>
    </sec>
    <sec id="s2" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="s2a">
        <title>Literature search strategy</title>
        <p>We searched the PubMed, Embase, and ISI Web of Science for all articles on the association between <italic>CYP2C9</italic> polymorphisms and CRC risk published before the end of May 2012. The following keywords were used: “colorectal” or “colo*,” “cancer” or “tumor” or “carcinoma,” and “<italic>CYP2C9</italic>” or “cytochrome P450 2C9”. Additional studies were identified by a hand search of references of original studies and review articles on the association between the <italic>CYP2C9</italic> polymorphism and CRC. No language restrictions were applied.</p>
      </sec>
      <sec id="s2b">
        <title>Inclusion and exclusion criteria</title>
        <p>We reviewed abstracts of all citations and retrieved studies. The following criteria were used to include published studies: (i) identification of colorectal cancer cases was confirmed histologically or pathologically, (ii) case–control or cohort studies to evaluate the association between <italic>CYP2C9</italic> *2 or *3 polymorphism and CRC risk and (iii) genotype distribution information in cases and controls or odds ratio (OR) with its 95% confidence interval (CI) and P-value. Major reasons for exclusion of studies were (i) review, or editorial, or comment; (ii) duplicated studies; (iii) no sufficient data were reported.</p>
      </sec>
      <sec id="s2c">
        <title>Data abstraction</title>
        <p>Two investigators extracted information from all eligible publications independently according to the inclusion criteria listed above. Disagreements were resolved by discussion with co-authors. For each included study, the following information was extracted from each report according to a fixed protocol: first author's surname, publication year, definition and numbers of cases and controls, diagnostic criterion, frequency of genotypes, source of controls, gender, age, Hardy–Weinberg equilibrium (HWE) status, ethnicity and genotyping method.</p>
      </sec>
      <sec id="s2d">
        <title>Statistical methods</title>
        <p>We first assessed HWE in the controls for each study using goodness-of-fit test (chi-square or Fisher's exact test) and a P&lt;0.05 was considered as significant disequilibrium. The strength of the association between CRC and the <italic>CYP2C9</italic> *2 and *3 polymorphism was estimated using ORs, with the corresponding 95% CIs. For the *2 polymorphism, we first estimated the risks of the *2 heterozygous and *2 homozygote genotypes on CRC, compared with the wild-type *1 homozygote. The risk of *2 carrier versus *1 on cancers was then evaluated in dominant model. The same evaluation was carried out for the *3 polymorphism.</p>
        <p>Both the Cochran's Q statistic <xref ref-type="bibr" rid="pone.0060607-Cochran1">[13]</xref> to test for heterogeneity and the I<sup>2</sup> statistic to quantify the proportion of the total variation due to heterogeneity <xref ref-type="bibr" rid="pone.0060607-Higgins1">[14]</xref> were calculated. Random-effects and fixed-effect summary measures were calculated as inverse-variance-weighted average of the log odds ratio. The results of random-effects summary were reported in the text because it takes into account the variation between studies. The significance of the overall OR was determined by the Z-test. Subsidiary analyses included subgroup analyses or random-effects meta-regression with restricted maximum likelihood <xref ref-type="bibr" rid="pone.0060607-Thompson1">[15]</xref>. Ethnicity (Caucasian vs Asian), HWE status among control (yes or no), diagnostic criterion (ICD-9 vs. others), sample size (≥500 cases or &lt;500 cases) and sex were pre-specified as characteristics for the assessment of heterogeneity. Ethnicity, sample size, HWE status, and sex distribution in cases and controls were analyzed as covariates in meta-regression.</p>
        <p>In order to assess the stability of the results, one-way sensitivity analyses were performed by removing each individual study in turn from the total and re-analyzing the remainder. Egger's regression test and funnel-plot analysis were used to assess publication bias <xref ref-type="bibr" rid="pone.0060607-Begg1">[16]</xref>, <xref ref-type="bibr" rid="pone.0060607-Egger1">[17]</xref>. Analyses were performed using the STATA software version 10.0 (Stata Corporation, College Station, TX, USA). All P values are two-sided at the P = 0.05 level.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Characteristics of studies</title>
        <p>There were 63 papers relevant to the searching terms. The study selection process is shown in <xref ref-type="supplementary-material" rid="pone.0060607.s001">Figure S1</xref>. A total of 13 studies examined the association between the <italic>CYP2C9</italic> polymorphism and CRC were included in the current meta-analysis <xref ref-type="bibr" rid="pone.0060607-Sainz1">[18]</xref>–<xref ref-type="bibr" rid="pone.0060607-Martnez1">[30]</xref>. Among them, 12 studies were identified for the <italic>CYP2C9</italic> *2 polymorphism, including a total of 9154 cases and 10900 controls, and for the *3 polymorphism 12 studies were identified covering a total of 7701 cases and 9287 controls. Characteristics of studies included in the current meta-analysis are presented in <xref ref-type="table" rid="pone-0060607-t001">Table 1</xref>.</p>
        <table-wrap id="pone-0060607-t001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0060607.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Characteristics of the studies included in the meta-analysis.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0060607-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0060607.t001" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Reference</td>
                  <td align="left" rowspan="1" colspan="1">Year</td>
                  <td align="left" rowspan="1" colspan="1">Ethnicity</td>
                  <td align="left" rowspan="1" colspan="1">Case</td>
                  <td align="left" rowspan="1" colspan="1">Control</td>
                  <td align="left" rowspan="1" colspan="1">No. of case</td>
                  <td align="left" rowspan="1" colspan="1">No. of control</td>
                  <td align="left" rowspan="1" colspan="1">Sex in case/control (male%)</td>
                  <td colspan="2" align="left" rowspan="1">MAF in controls</td>
                  <td align="left" rowspan="1" colspan="1">Genotyping method</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>CYP2C9</italic>*2</td>
                  <td align="left" rowspan="1" colspan="1"><italic>CYP2C9</italic>*3</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sainz <xref ref-type="bibr" rid="pone.0060607-Sainz1">[18]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2011</td>
                  <td align="left" rowspan="1" colspan="1">German</td>
                  <td align="left" rowspan="1" colspan="1">ICD-10</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">1768</td>
                  <td align="left" rowspan="1" colspan="1">1783</td>
                  <td align="left" rowspan="1" colspan="1">58.6/59.8</td>
                  <td align="left" rowspan="1" colspan="1">0.12</td>
                  <td align="left" rowspan="1" colspan="1">0.06</td>
                  <td align="left" rowspan="1" colspan="1">KASPar assay</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cleary <xref ref-type="bibr" rid="pone.0060607-Cleary1">[19]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2010</td>
                  <td align="left" rowspan="1" colspan="1">Canadian</td>
                  <td align="left" rowspan="1" colspan="1">ICD-9</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">1165</td>
                  <td align="left" rowspan="1" colspan="1">1292</td>
                  <td align="left" rowspan="1" colspan="1">41.0/56.0</td>
                  <td align="left" rowspan="1" colspan="1">0.14</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">Taqman</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Northwood <xref ref-type="bibr" rid="pone.0060607-Northwood1">[20]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2010</td>
                  <td align="left" rowspan="1" colspan="1">British</td>
                  <td align="left" rowspan="1" colspan="1">Colonoscopy confirmed</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">308</td>
                  <td align="left" rowspan="1" colspan="1">296</td>
                  <td align="left" rowspan="1" colspan="1">71.3/58.8</td>
                  <td align="left" rowspan="1" colspan="1">0.11</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">Taqman</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Buyukdogan <xref ref-type="bibr" rid="pone.0060607-Buyukdogan1">[21]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2009</td>
                  <td align="left" rowspan="1" colspan="1">Turkish</td>
                  <td align="left" rowspan="1" colspan="1">CRC patients</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">77</td>
                  <td align="left" rowspan="1" colspan="1">78</td>
                  <td align="left" rowspan="1" colspan="1">52.0/53.0</td>
                  <td align="left" rowspan="1" colspan="1">0.11</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">RT-PCR</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cotterchio <xref ref-type="bibr" rid="pone.0060607-Cotterchio1">[22]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2008</td>
                  <td align="left" rowspan="1" colspan="1">Canadian</td>
                  <td align="left" rowspan="1" colspan="1">ICD-9</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">834</td>
                  <td align="left" rowspan="1" colspan="1">1249</td>
                  <td align="left" rowspan="1" colspan="1">NA/NA</td>
                  <td align="left" rowspan="1" colspan="1">0.14</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">Taqman</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Liao <xref ref-type="bibr" rid="pone.0060607-Liao1">[23]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2007</td>
                  <td align="left" rowspan="1" colspan="1">Chinese</td>
                  <td align="left" rowspan="1" colspan="1">CRC patients</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">284</td>
                  <td align="left" rowspan="1" colspan="1">483</td>
                  <td align="left" rowspan="1" colspan="1">54.5/53.6</td>
                  <td align="left" rowspan="1" colspan="1">/</td>
                  <td align="left" rowspan="1" colspan="1">0.03</td>
                  <td align="left" rowspan="1" colspan="1">Sequencing</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Küry <xref ref-type="bibr" rid="pone.0060607-Kry1">[24]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2007</td>
                  <td align="left" rowspan="1" colspan="1">French</td>
                  <td align="left" rowspan="1" colspan="1">CRC patients</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">1013</td>
                  <td align="left" rowspan="1" colspan="1">1118</td>
                  <td align="left" rowspan="1" colspan="1">62.0/54.0</td>
                  <td align="left" rowspan="1" colspan="1">0.14</td>
                  <td align="left" rowspan="1" colspan="1">/</td>
                  <td align="left" rowspan="1" colspan="1">Taqman</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Samowitz <xref ref-type="bibr" rid="pone.0060607-Samowitz1">[25]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2006</td>
                  <td align="left" rowspan="1" colspan="1">American</td>
                  <td align="left" rowspan="1" colspan="1">ICD-9</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">2295</td>
                  <td align="left" rowspan="1" colspan="1">2903</td>
                  <td align="left" rowspan="1" colspan="1">57.1/54.6</td>
                  <td align="left" rowspan="1" colspan="1">0.18</td>
                  <td align="left" rowspan="1" colspan="1">0.02</td>
                  <td align="left" rowspan="1" colspan="1">RFLP, TaqMan</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">McGreavey <xref ref-type="bibr" rid="pone.0060607-McGreavey1">[26]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2005</td>
                  <td align="left" rowspan="1" colspan="1">British</td>
                  <td align="left" rowspan="1" colspan="1">ICD-9</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">490</td>
                  <td align="left" rowspan="1" colspan="1">592</td>
                  <td align="left" rowspan="1" colspan="1">61.0/54.0</td>
                  <td align="left" rowspan="1" colspan="1">0.14</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">Taqman</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Tranah <xref ref-type="bibr" rid="pone.0060607-Tranah1">[27]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2005</td>
                  <td align="left" rowspan="1" colspan="1">American</td>
                  <td align="left" rowspan="1" colspan="1">CRC patients</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">416</td>
                  <td align="left" rowspan="1" colspan="1">825</td>
                  <td align="left" rowspan="1" colspan="1">0/0</td>
                  <td align="left" rowspan="1" colspan="1">0.17</td>
                  <td align="left" rowspan="1" colspan="1">0.08</td>
                  <td align="left" rowspan="1" colspan="1">Taqman</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Landi <xref ref-type="bibr" rid="pone.0060607-Landi1">[28]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2005</td>
                  <td align="left" rowspan="1" colspan="1">Spanish</td>
                  <td align="left" rowspan="1" colspan="1">CRC patients</td>
                  <td align="left" rowspan="1" colspan="1">Cancer free</td>
                  <td align="left" rowspan="1" colspan="1">364</td>
                  <td align="left" rowspan="1" colspan="1">324</td>
                  <td align="left" rowspan="1" colspan="1">NA/NA</td>
                  <td align="left" rowspan="1" colspan="1">0.13</td>
                  <td align="left" rowspan="1" colspan="1">0.08</td>
                  <td align="left" rowspan="1" colspan="1">Sequencing</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Chan <xref ref-type="bibr" rid="pone.0060607-Chan1">[29]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2004</td>
                  <td align="left" rowspan="1" colspan="1">American</td>
                  <td align="left" rowspan="1" colspan="1">Histology confirmed</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">339</td>
                  <td align="left" rowspan="1" colspan="1">350</td>
                  <td align="left" rowspan="1" colspan="1">0/0</td>
                  <td align="left" rowspan="1" colspan="1">0.09</td>
                  <td align="left" rowspan="1" colspan="1">0.08</td>
                  <td align="left" rowspan="1" colspan="1">Taqman</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Martínez <xref ref-type="bibr" rid="pone.0060607-Martnez1">[30]</xref></td>
                  <td align="left" rowspan="1" colspan="1">2001</td>
                  <td align="left" rowspan="1" colspan="1">Spanish</td>
                  <td align="left" rowspan="1" colspan="1">Histology confirmed</td>
                  <td align="left" rowspan="1" colspan="1">Healthy</td>
                  <td align="left" rowspan="1" colspan="1">110</td>
                  <td align="left" rowspan="1" colspan="1">123</td>
                  <td align="left" rowspan="1" colspan="1">53.0/53.0</td>
                  <td align="left" rowspan="1" colspan="1">0.19</td>
                  <td align="left" rowspan="1" colspan="1">0.20</td>
                  <td align="left" rowspan="1" colspan="1">RFLP</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>ICD: International Classification of Diseases, HB: hospital-based, PB: population-based, MAF: minor allele frequency, NA: not available.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s3b">
        <title>CYP2C*2 and CRC risk</title>
        <p>The pooled estimate for CRC risk of <italic>CYP2C9</italic> *2 polymorphism is shown in <xref ref-type="fig" rid="pone-0060607-g001">Figure? 1</xref>. The comparison between CRC cases and controls was investigated in 15 data sets. Overall, there was no significant heterogeneity among the studies concerning CRC risk of <italic>CYP2C9</italic> *2 polymorphism (P&gt;0.05). The combined OR from the fixed-effects model was not significant with OR of 0.94 (95% CI: 0.87–1.03, P = 0.18) for the variant carriers. Similarly, no significant associations were found for heterozygous (OR = 0.92, 95% CI: 0.85–1.00, P = 0.06) and homozygous (OR = 1.19, 95% CI: 0.98–1.45, P = 0.07) when compared with wild genotype. Subgroup analysis for CRC risk of <italic>CYP2C9</italic> *2 was also performed to explore the sources of heterogeneity. In the subgroup analyses by ethnicity, sample size, HWE status, diagnostic criteria and sex, no significant results were found in almost all genetic models (<xref ref-type="table" rid="pone-0060607-t002">Table 2</xref>).</p>
        <fig id="pone-0060607-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0060607.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Forest plot (random effects model) of colorectal cancer risk associated with the CYP2C9 *2 carrier of the R144C polymorphism.</title>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0060607.g001" position="float" xlink:type="simple"/>
        </fig>
        <table-wrap id="pone-0060607-t002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0060607.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Meta-analysis of the <italic>CYP2C9</italic> *2 polymorphism on colorectal cancer susceptibility.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0060607-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0060607.t002" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sub-group analysis</td>
                  <td align="left" rowspan="1" colspan="1">No. of data sets</td>
                  <td align="left" rowspan="1" colspan="1">No. of case/control</td>
                  <td colspan="4" align="left" rowspan="1">Heterozygous</td>
                  <td colspan="4" align="left" rowspan="1">Homozygous</td>
                  <td colspan="4" align="left" rowspan="1">Variant carrier</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">OR (95%CI)</td>
                  <td align="left" rowspan="1" colspan="1">P(Z)</td>
                  <td align="left" rowspan="1" colspan="1">P(Q)</td>
                  <td align="left" rowspan="1" colspan="1">I<sup>2</sup></td>
                  <td align="left" rowspan="1" colspan="1">OR (95%CI)</td>
                  <td align="left" rowspan="1" colspan="1">P(Z)</td>
                  <td align="left" rowspan="1" colspan="1">P(Q)</td>
                  <td align="left" rowspan="1" colspan="1">I<sup>2</sup></td>
                  <td align="left" rowspan="1" colspan="1">OR (95%CI)</td>
                  <td align="left" rowspan="1" colspan="1">P(Z)</td>
                  <td align="left" rowspan="1" colspan="1">P(Q)</td>
                  <td align="left" rowspan="1" colspan="1">I<sup>2</sup></td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Total</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">9154/10900</td>
                  <td align="left" rowspan="1" colspan="1">0.92 (0.85–1.00)</td>
                  <td align="left" rowspan="1" colspan="1">0.06</td>
                  <td align="left" rowspan="1" colspan="1">0.12</td>
                  <td align="left" rowspan="1" colspan="1">31%</td>
                  <td align="left" rowspan="1" colspan="1">1.19 (0.98–1.45)</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">0.50</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.94 (0.87–1.03)</td>
                  <td align="left" rowspan="1" colspan="1">0.18</td>
                  <td align="left" rowspan="1" colspan="1">0.09</td>
                  <td align="left" rowspan="1" colspan="1">35%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ethnicity</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Caucasian</td>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">9077/10822</td>
                  <td align="left" rowspan="1" colspan="1">0.92 (0.85–1.01)</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">0.09</td>
                  <td align="left" rowspan="1" colspan="1">35%</td>
                  <td align="left" rowspan="1" colspan="1">1.20 (0.99–1.46)</td>
                  <td align="left" rowspan="1" colspan="1">0.06</td>
                  <td align="left" rowspan="1" colspan="1">0.46</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.95 (0.87–1.03)</td>
                  <td align="left" rowspan="1" colspan="1">0.21</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">39%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Asian</td>
                  <td align="left" rowspan="1" colspan="1">1</td>
                  <td align="left" rowspan="1" colspan="1">77/78</td>
                  <td align="left" rowspan="1" colspan="1">0.72 (0.28–1.82)</td>
                  <td align="left" rowspan="1" colspan="1">0.48</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">0.64 (0.10–3.94)</td>
                  <td align="left" rowspan="1" colspan="1">0.63</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">0.70 (0.30–1.64)</td>
                  <td align="left" rowspan="1" colspan="1">0.41</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sample size</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&lt;500</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">2093/2566</td>
                  <td align="left" rowspan="1" colspan="1">0.93 (0.76–1.14)</td>
                  <td align="left" rowspan="1" colspan="1">0.50</td>
                  <td align="left" rowspan="1" colspan="1">0.06</td>
                  <td align="left" rowspan="1" colspan="1">48%</td>
                  <td align="left" rowspan="1" colspan="1">1.40 (0.86–2.29)</td>
                  <td align="left" rowspan="1" colspan="1">0.18</td>
                  <td align="left" rowspan="1" colspan="1">0.18</td>
                  <td align="left" rowspan="1" colspan="1">31%</td>
                  <td align="left" rowspan="1" colspan="1">0.97 (0.78–1.20)</td>
                  <td align="left" rowspan="1" colspan="1">0.77</td>
                  <td align="left" rowspan="1" colspan="1">0.03</td>
                  <td align="left" rowspan="1" colspan="1">55%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">≥500</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">7061/8334</td>
                  <td align="left" rowspan="1" colspan="1">0.92 (0.85–0.99)</td>
                  <td align="left" rowspan="1" colspan="1">0.03</td>
                  <td align="left" rowspan="1" colspan="1">0.35</td>
                  <td align="left" rowspan="1" colspan="1">10%</td>
                  <td align="left" rowspan="1" colspan="1">1.13 (0.91–1.42)</td>
                  <td align="left" rowspan="1" colspan="1">0.27</td>
                  <td align="left" rowspan="1" colspan="1">0.88</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.93 (0.87–1.00)</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">0.48</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HWE status</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">9077/10822</td>
                  <td align="left" rowspan="1" colspan="1">0.92 (0.85–1.01)</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">0.09</td>
                  <td align="left" rowspan="1" colspan="1">35%</td>
                  <td align="left" rowspan="1" colspan="1">1.20 (0.99–1.46)</td>
                  <td align="left" rowspan="1" colspan="1">0.06</td>
                  <td align="left" rowspan="1" colspan="1">0.46</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.95 (0.87–1.03)</td>
                  <td align="left" rowspan="1" colspan="1">0.21</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">39%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">No</td>
                  <td align="left" rowspan="1" colspan="1">1</td>
                  <td align="left" rowspan="1" colspan="1">77/78</td>
                  <td align="left" rowspan="1" colspan="1">0.72 (0.28–1.82)</td>
                  <td align="left" rowspan="1" colspan="1">0.48</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">0.64 (0.10–3.94)</td>
                  <td align="left" rowspan="1" colspan="1">0.63</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">0.70 (0.30–1.64)</td>
                  <td align="left" rowspan="1" colspan="1">0.41</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Diagnostic criterion</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ICD criterion</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">6538/7808</td>
                  <td align="left" rowspan="1" colspan="1">0.90 (0.83–0.98)</td>
                  <td align="left" rowspan="1" colspan="1">0.01</td>
                  <td align="left" rowspan="1" colspan="1">0.38</td>
                  <td align="left" rowspan="1" colspan="1">6%</td>
                  <td align="left" rowspan="1" colspan="1">1.11 (0.88–1.40)</td>
                  <td align="left" rowspan="1" colspan="1">0.37</td>
                  <td align="left" rowspan="1" colspan="1">0.92</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.92 (0.85–0.99)</td>
                  <td align="left" rowspan="1" colspan="1">0.03</td>
                  <td align="left" rowspan="1" colspan="1">0.54</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Other criterion</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">2616/3092</td>
                  <td align="left" rowspan="1" colspan="1">0.95 (0.79–1.15)</td>
                  <td align="left" rowspan="1" colspan="1">0.62</td>
                  <td align="left" rowspan="1" colspan="1">0.07</td>
                  <td align="left" rowspan="1" colspan="1">47%</td>
                  <td align="left" rowspan="1" colspan="1">1.44 (0.90–2.29)</td>
                  <td align="left" rowspan="1" colspan="1">0.13</td>
                  <td align="left" rowspan="1" colspan="1">0.19</td>
                  <td align="left" rowspan="1" colspan="1">30%</td>
                  <td align="left" rowspan="1" colspan="1">0.99 (0.81–1.20)</td>
                  <td align="left" rowspan="1" colspan="1">0.92</td>
                  <td align="left" rowspan="1" colspan="1">0.03</td>
                  <td align="left" rowspan="1" colspan="1">54%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sex</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Male</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">1273/1455</td>
                  <td align="left" rowspan="1" colspan="1">0.79 (0.52–1.18)</td>
                  <td align="left" rowspan="1" colspan="1">0.25</td>
                  <td align="left" rowspan="1" colspan="1">0.06</td>
                  <td align="left" rowspan="1" colspan="1">71%</td>
                  <td align="left" rowspan="1" colspan="1">1.27 (0.77–2.11)</td>
                  <td align="left" rowspan="1" colspan="1">0.35</td>
                  <td align="left" rowspan="1" colspan="1">0.60</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.83 (0.59–1.18)</td>
                  <td align="left" rowspan="1" colspan="1">0.31</td>
                  <td align="left" rowspan="1" colspan="1">0.09</td>
                  <td align="left" rowspan="1" colspan="1">66%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Female</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">1238/1492</td>
                  <td align="left" rowspan="1" colspan="1">1.11 (0.85–1.44)</td>
                  <td align="left" rowspan="1" colspan="1">0.46</td>
                  <td align="left" rowspan="1" colspan="1">0.17</td>
                  <td align="left" rowspan="1" colspan="1">44%</td>
                  <td align="left" rowspan="1" colspan="1">0.92 (0.34–2.45)</td>
                  <td align="left" rowspan="1" colspan="1">0.86</td>
                  <td align="left" rowspan="1" colspan="1">0.10</td>
                  <td align="left" rowspan="1" colspan="1">57%</td>
                  <td align="left" rowspan="1" colspan="1">1.09 (0.79–1.51)</td>
                  <td align="left" rowspan="1" colspan="1">0.60</td>
                  <td align="left" rowspan="1" colspan="1">0.06</td>
                  <td align="left" rowspan="1" colspan="1">64%</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt102">
              <label/>
              <p>NA: not available.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Although the formal test for heterogeneity was not significant, we conducted meta-regression as there were also grounds for considering the ethnicity, sample size, HWE status, and sex distribution among cases and controls as potential sources of heterogeneity. However, the meta-regression showed that none of these covariates significantly contributed to the heterogeneity among the individual study results (P&gt;0.05 for all).</p>
      </sec>
      <sec id="s3c">
        <title>CYP2C9 *3 and CRC risk</title>
        <p>Overall, the variant genotypes of the <italic>CYP2C9</italic> *3 were not associated with CRC risk when compared with the wild-type *1 homozygote (*3 heterozygous: OR = 1.00, 95% CI = 0.86–1.17, P = 0.99; *3 homozygous: OR = 0.87, 95% CI = 0.43–1.74, P = 0.69). Similarly, no associations were observed in the dominant genetic model (OR = 1.00, 95% CI = 0.86–1.16, P = 0.99; <xref ref-type="fig" rid="pone-0060607-g002">Figure 2</xref>). On the basis of the potential underestimation of the true effect of the polymorphism on the CRC risk, we stratified these studies according to ethnicity, sample size, HWE status, diagnostic criteria and sex. In stratified analyses, the variant genotypes had no significant relationship with CRC in all of the subgroups, compared with wild-type. Similar results were observed in the dominant genetic model (<xref ref-type="table" rid="pone-0060607-t003">Table 3</xref>)</p>
        <fig id="pone-0060607-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0060607.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Forest plot (random effects model) of colorectal cancer risk associated with the CYP2C9 *3 carrier of the I359L polymorphism.</title>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0060607.g002" position="float" xlink:type="simple"/>
        </fig>
        <table-wrap id="pone-0060607-t003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0060607.t003</object-id>
          <label>Table 3</label>
          <caption>
            <title>Meta-analysis of the <italic>CYP2C9</italic> *3 polymorphism on colorectal cancer susceptibility.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0060607-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0060607.t003" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sub-group analysis</td>
                  <td align="left" rowspan="1" colspan="1">No. of data sets</td>
                  <td align="left" rowspan="1" colspan="1">No. of case/control</td>
                  <td colspan="4" align="left" rowspan="1">Heterozygous</td>
                  <td colspan="4" align="left" rowspan="1">Homozygous</td>
                  <td colspan="4" align="left" rowspan="1">Variant carrier</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">OR (95%CI)</td>
                  <td align="left" rowspan="1" colspan="1">P(Z)</td>
                  <td align="left" rowspan="1" colspan="1">P(Q)</td>
                  <td align="left" rowspan="1" colspan="1">I<sup>2</sup></td>
                  <td align="left" rowspan="1" colspan="1">OR (95%CI)</td>
                  <td align="left" rowspan="1" colspan="1">P(Z)</td>
                  <td align="left" rowspan="1" colspan="1">P(Q)</td>
                  <td align="left" rowspan="1" colspan="1">I<sup>2</sup></td>
                  <td align="left" rowspan="1" colspan="1">OR (95%CI)</td>
                  <td align="left" rowspan="1" colspan="1">P(Z)</td>
                  <td align="left" rowspan="1" colspan="1">P(Q)</td>
                  <td align="left" rowspan="1" colspan="1">I<sup>2</sup></td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Total</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">7701/9287</td>
                  <td align="left" rowspan="1" colspan="1">1.00 (0.86–1.17)</td>
                  <td align="left" rowspan="1" colspan="1">0.99</td>
                  <td align="left" rowspan="1" colspan="1">0.007</td>
                  <td align="left" rowspan="1" colspan="1">54%</td>
                  <td align="left" rowspan="1" colspan="1">0.87 (0.43–1.74)</td>
                  <td align="left" rowspan="1" colspan="1">0.69</td>
                  <td align="left" rowspan="1" colspan="1">0.32</td>
                  <td align="left" rowspan="1" colspan="1">14%</td>
                  <td align="left" rowspan="1" colspan="1">1.00 (0.86–1.16)</td>
                  <td align="left" rowspan="1" colspan="1">0.99</td>
                  <td align="left" rowspan="1" colspan="1">0.008</td>
                  <td align="left" rowspan="1" colspan="1">53%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ethnicity</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Caucasian</td>
                  <td align="left" rowspan="1" colspan="1">13</td>
                  <td align="left" rowspan="1" colspan="1">7343/8734</td>
                  <td align="left" rowspan="1" colspan="1">0.96 (0.85–1.08)</td>
                  <td align="left" rowspan="1" colspan="1">0.49</td>
                  <td align="left" rowspan="1" colspan="1">0.18</td>
                  <td align="left" rowspan="1" colspan="1">26%</td>
                  <td align="left" rowspan="1" colspan="1">0.87 (0.43–1.74)</td>
                  <td align="left" rowspan="1" colspan="1">0.69</td>
                  <td align="left" rowspan="1" colspan="1">0.32</td>
                  <td align="left" rowspan="1" colspan="1">14%</td>
                  <td align="left" rowspan="1" colspan="1">0.96 (0.85–1.07)</td>
                  <td align="left" rowspan="1" colspan="1">0.45</td>
                  <td align="left" rowspan="1" colspan="1">0.20</td>
                  <td align="left" rowspan="1" colspan="1">24%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Asian</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">358/553</td>
                  <td align="left" rowspan="1" colspan="1">1.92 (0.87–4.25)</td>
                  <td align="left" rowspan="1" colspan="1">0.11</td>
                  <td align="left" rowspan="1" colspan="1">0.16</td>
                  <td align="left" rowspan="1" colspan="1">50%</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">1.92 (0.87–4.25)</td>
                  <td align="left" rowspan="1" colspan="1">0.11</td>
                  <td align="left" rowspan="1" colspan="1">0.16</td>
                  <td align="left" rowspan="1" colspan="1">50%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sample size</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">&lt;500</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">2314/2933</td>
                  <td align="left" rowspan="1" colspan="1">0.99 (0.74–1.33)</td>
                  <td align="left" rowspan="1" colspan="1">0.95</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">69%</td>
                  <td align="left" rowspan="1" colspan="1">1.44 (0.49–4.19)</td>
                  <td align="left" rowspan="1" colspan="1">0.51</td>
                  <td align="left" rowspan="1" colspan="1">0.56</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">1.00 (0.75–1.33)</td>
                  <td align="left" rowspan="1" colspan="1">0.99</td>
                  <td align="left" rowspan="1" colspan="1">0.002</td>
                  <td align="left" rowspan="1" colspan="1">68%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">≥500</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">5387/6354</td>
                  <td align="left" rowspan="1" colspan="1">1.00 (0.88–1.13)</td>
                  <td align="left" rowspan="1" colspan="1">0.97</td>
                  <td align="left" rowspan="1" colspan="1">0.46</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.65 (0.25–1.66)</td>
                  <td align="left" rowspan="1" colspan="1">0.37</td>
                  <td align="left" rowspan="1" colspan="1">0.23</td>
                  <td align="left" rowspan="1" colspan="1">27%</td>
                  <td align="left" rowspan="1" colspan="1">0.98 (0.87–1.11)</td>
                  <td align="left" rowspan="1" colspan="1">0.76</td>
                  <td align="left" rowspan="1" colspan="1">0.40</td>
                  <td align="left" rowspan="1" colspan="1">2%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">HWE status</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Yes</td>
                  <td align="left" rowspan="1" colspan="1">13</td>
                  <td align="left" rowspan="1" colspan="1">7443/8786</td>
                  <td align="left" rowspan="1" colspan="1">1.05 (0.90–1.22)</td>
                  <td align="left" rowspan="1" colspan="1">0.52</td>
                  <td align="left" rowspan="1" colspan="1">0.02</td>
                  <td align="left" rowspan="1" colspan="1">49%</td>
                  <td align="left" rowspan="1" colspan="1">0.87 (0.43–1.74)</td>
                  <td align="left" rowspan="1" colspan="1">0.69</td>
                  <td align="left" rowspan="1" colspan="1">0.32</td>
                  <td align="left" rowspan="1" colspan="1">14%</td>
                  <td align="left" rowspan="1" colspan="1">1.05 (0.90–1.21)</td>
                  <td align="left" rowspan="1" colspan="1">0.54</td>
                  <td align="left" rowspan="1" colspan="1">0.02</td>
                  <td align="left" rowspan="1" colspan="1">49%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">No</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">258/521</td>
                  <td align="left" rowspan="1" colspan="1">0.65 (0.42–1.01)</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">0.25</td>
                  <td align="left" rowspan="1" colspan="1">25%</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">0.65 (0.42–1.01)</td>
                  <td align="left" rowspan="1" colspan="1">0.05</td>
                  <td align="left" rowspan="1" colspan="1">0.25</td>
                  <td align="left" rowspan="1" colspan="1">25%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Diagnostic criterion</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">ICD criterion</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">5877/6946</td>
                  <td align="left" rowspan="1" colspan="1">1.01 (0.90–1.14)</td>
                  <td align="left" rowspan="1" colspan="1">0.85</td>
                  <td align="left" rowspan="1" colspan="1">0.53</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.66 (0.31–1.38)</td>
                  <td align="left" rowspan="1" colspan="1">0.27</td>
                  <td align="left" rowspan="1" colspan="1">0.33</td>
                  <td align="left" rowspan="1" colspan="1">13%</td>
                  <td align="left" rowspan="1" colspan="1">0.99 (0.89–1.11)</td>
                  <td align="left" rowspan="1" colspan="1">0.91</td>
                  <td align="left" rowspan="1" colspan="1">0.48</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Other criterion</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">1824/2341</td>
                  <td align="left" rowspan="1" colspan="1">0.97 (0.69–1.36)</td>
                  <td align="left" rowspan="1" colspan="1">0.85</td>
                  <td align="left" rowspan="1" colspan="1">0.0007</td>
                  <td align="left" rowspan="1" colspan="1">72%</td>
                  <td align="left" rowspan="1" colspan="1">3.32 (0.67–16.49)</td>
                  <td align="left" rowspan="1" colspan="1">0.14</td>
                  <td align="left" rowspan="1" colspan="1">0.92</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.98 (0.70–1.38)</td>
                  <td align="left" rowspan="1" colspan="1">0.92</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">71%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Sex</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Male</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">1257/1391</td>
                  <td align="left" rowspan="1" colspan="1">0.84 (0.67–1.06)</td>
                  <td align="left" rowspan="1" colspan="1">0.15</td>
                  <td align="left" rowspan="1" colspan="1">0.66</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.67 (0.11–4.02)</td>
                  <td align="left" rowspan="1" colspan="1">0.66</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">NA</td>
                  <td align="left" rowspan="1" colspan="1">0.84 (0.67–1.06)</td>
                  <td align="left" rowspan="1" colspan="1">0.14</td>
                  <td align="left" rowspan="1" colspan="1">0.65</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Female</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">1199/1437</td>
                  <td align="left" rowspan="1" colspan="1">1.14 (0.88–1.49)</td>
                  <td align="left" rowspan="1" colspan="1">0.32</td>
                  <td align="left" rowspan="1" colspan="1">0.27</td>
                  <td align="left" rowspan="1" colspan="1">24%</td>
                  <td align="left" rowspan="1" colspan="1">2.10 (0.52–8.43)</td>
                  <td align="left" rowspan="1" colspan="1">0.29</td>
                  <td align="left" rowspan="1" colspan="1">0.94</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">1.15 (0.88–1.52)</td>
                  <td align="left" rowspan="1" colspan="1">0.30</td>
                  <td align="left" rowspan="1" colspan="1">0.25</td>
                  <td align="left" rowspan="1" colspan="1">29%</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt103">
              <label/>
              <p>NA: not available.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>In meta-regression analysis, sample size (p = 0.93), gender of cases (P = 0.34) and controls (P = 0.37), diagnostic criteria (P = 0.91) and the status of Hardy–Weinberg equilibrium (p = 0.05) did not significantly explained such heterogeneity. By contrast, ethnicity (P = 0.001) were significantly correlated with the magnitude of the genetic effect.</p>
      </sec>
      <sec id="s3d">
        <title>Sensitivity analyses and Publication bias</title>
        <p>A single study involved in the meta-analysis was deleted each time to reflect the influence of the individual dataset to the pooled ORs, and the corresponding pooled ORs were not qualitatively altered, suggesting that the results of this meta-analysis are stable (<xref ref-type="supplementary-material" rid="pone.0060607.s002">Figure S2</xref> and <xref ref-type="supplementary-material" rid="pone.0060607.s003">S3</xref>). In addition, when excluding the studies that were not in HWE, the results were persistent and robust (<xref ref-type="table" rid="pone-0060607-t002">Table 2</xref> and <xref ref-type="table" rid="pone-0060607-t003">3</xref>). The shape of the funnel plot did not indicate any evidence of obvious asymmetry (<xref ref-type="supplementary-material" rid="pone.0060607.s004">Figure S4</xref> and <xref ref-type="supplementary-material" rid="pone.0060607.s005">S5</xref>), thus suggesting no publication bias among the studies included. The statistical results still did not show preferential publication of positive findings in smaller studies (Egger test, P = 0.96 for *2 carrier; P = 0.95 for *3 carrier).</p>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>A number of factors predict CRC; however, detailed mechanisms of CRC remain a matter of speculation. However, accumulative evidences have suggested an important role for genetics in determining risk for CRC <xref ref-type="bibr" rid="pone.0060607-Lichtenstein1">[2]</xref>. Association studies are appropriate for searching susceptibility genes involved in CRC <xref ref-type="bibr" rid="pone.0060607-Risch1">[31]</xref>. CYP2C9 is a key P450 enzyme implicated in the metabolism of exogenous and endogenous substrates. A variety of studies have demonstrated that the metabolism of polycyclic aromatic hydrocarbons and other procarcinogens through CYP2C9 may well lead to the activation of the carcinogenic compounds <xref ref-type="bibr" rid="pone.0060607-Cleary1">[19]</xref>, <xref ref-type="bibr" rid="pone.0060607-Tranah1">[27]</xref>. <italic>CYP2C9</italic> is a polymorphic gene in the human population; the genetic variations have been studied with respect to a variety of cancer types. In recent years, a number of molecular epidemiologic studies have been conducted to evaluate the role of *2 and *3 polymorphisms in the <italic>CYP2C9</italic> gene on CRC risk; however, the results remain conflicting rather than conclusive. As a powerful statistical method, meta-analysis can provide a quantitative approach for pooling the results of different research on the same topic, and thus a quantitative assessment of association between <italic>CYP2C9</italic> polymorphism and CRC risk was of great value. The present meta-analysis, including 9463 cases and 11416 controls from 13 case–control studies, explored the association between the *2 and *3 polymorphism of <italic>CYP2C9</italic> gene and CRC risk. To the best of our knowledge, this is the first comprehensive meta-analysis concerning the relationship between <italic>CYP2C9</italic> polymorphism and CRC susceptibility. Overall, we did not find any significant association between <italic>CYP2C9</italic> *2, *3 polymorphism and CRC susceptibility. In the stratified analysis by ethnicity, sample size, HWE status, diagnostic criteria and sex, significant associations were still not observed in all genetic models. <italic>CYP2C9</italic> genotype was not found to be a determinant of colorectal cancer susceptibility according to the results of present meta-analysis.</p>
      <p>Although CYP2C9 is active in the metabolism of several commonly prescribed drugs, including warfarin, phenytoin and non-steroidal anti-inflammatory drugs (NSAIDs) <xref ref-type="bibr" rid="pone.0060607-Lee1">[32]</xref>, its role in xenobiotic and carcinogen metabolism is less well defined, although it has been shown to metabolize the carcinogen benzo[a]pyrene (B[a]P) to the highly mutagenic metabolite B[a]P-7,8diol-9,10-epoxide <xref ref-type="bibr" rid="pone.0060607-Shou1">[33]</xref>. <italic>CYP2C9</italic>*3 encodes a protein with approximately 5–30% of the activity of the common reference allele <xref ref-type="bibr" rid="pone.0060607-Takahashi1">[34]</xref>, and it could therefore be hypothesized that <italic>CYP2C9</italic>*3 allele carriers have reduced carcinogen activating ability and thus reduced disease risk. However, the increased CRC risk associated with <italic>CYP2C9</italic>*2 genotype in earlier studies suggests that the enzyme may play a more important role in detoxification of carcinogens.</p>
      <p>Epidemiological data indicated the use of NSAID is inversely associated with the risk of developing colorectal cancer <xref ref-type="bibr" rid="pone.0060607-Baron1">[35]</xref>. Metabolism of NSAIDs involves oxidation by CYP enzymes and/or conjugation, particularly glucuronidation by phase II enzymes. The major enzymes involved are CYP2C9 and UGT1A6, both enzymes have variant forms <xref ref-type="bibr" rid="pone.0060607-McGreavey1">[26]</xref>. The modulation of chemoprevention of NSAIDs on CRC risk by the genotype of <italic>CYP2C9</italic> and <italic>UGT1A6</italic> has been reported among Caucasian population <xref ref-type="bibr" rid="pone.0060607-McGreavey1">[26]</xref>, <xref ref-type="bibr" rid="pone.0060607-Haining1">[36]</xref>. Recently, the interaction between <italic>UGT1A6</italic> and <italic>CYP2C9</italic>, aspirin or ibuprofen use, and CRC risk were determined in 2295 CRC cases and 2903 controls. Their data showed the enhanced effect of slower-metabolizing <italic>CYP2C9</italic> variants on the chemopreventive activity of ibuprofen against CRC, and CYP variants were more effective in individuals with wild-type rather than variant <italic>UGT1A6</italic> <xref ref-type="bibr" rid="pone.0060607-Samowitz1">[25]</xref>. Therefore, the contribution of gene – gene interaction as well as gene – medication interaction should be considered in future study in elucidating the contribution of <italic>CYP2C9</italic> polymorphism to CRC etiology.</p>
      <p>Although there is no association between <italic>CYP2C9</italic> *2, *3 polymorphism and the risk of CRC, the associations between <italic>CYP2C9</italic> polymorphism and CRC risk might be modified when exposed to some factors such as tobacco smoking <xref ref-type="bibr" rid="pone.0060607-Chan1">[29]</xref>. Chan et al <xref ref-type="bibr" rid="pone.0060607-Chan1">[29]</xref> reported that <italic>CYP2C9</italic> genotypes modified the CRC risk associated with smoking status. Women with variant genotypes who smoked &gt;20 pack-years had a 2.5-fold greater odds of adenoma compared with women with wild-type genotypes who smoked ≤20 pack-years. Because of limited data in primary studies, we could not quantitatively analyze the modification effects of smoking on the relationships between <italic>CYP2C9</italic> polymorphisms and CRC risk.</p>
      <p>Limitations also inevitably existed in this meta-analysis. Firstly, most studies were conducted in Caucasian population. Therefore, it could be under powered to detected the interaction among Asian population in subgroup analysis. Hence, further studies including a wider spectrum of subjects should be carried to investigate the role of these variants in different populations. Secondly, our results were based on unadjusted estimates since we did not have original data. Therefore, we were not able to take into account other factors like obesity, inflammation, aspirin/NSAID use, vitamin D and vitamin E intake, which may modify the risk estimates, as reported in previous publications. Thus, assessment of the association between <italic>CYP2C9</italic> polymorphism and these covariates and CRC is needed in order to determine clearly the impact of <italic>CYP2C9</italic> polymorphism on the etiology of CRC. Thirdly, meta-analysis is a type of retrospective study, and the recall and selection bias might exist. In spite of these, our meta-analysis also had some advantages. First, substantial numbers of cases and controls were pooled from different studies, which significantly increased the statistical power of the analysis. Second, no publication bias was detected; indicating that the whole pooled result may be unbiased.</p>
      <p>In conclusion, this meta-analysis evaluates the relation-ship between genetic polymorphism and CRC risk and reveals that <italic>CYP2C9</italic> *2 and *3 polymorphism is not associated with altered susceptibility to CRC. As studies among other populations are currently limited, further studies including a wider spectrum of subjects should be carried to investigate the role of these variant in these populations, which should lead to better, comprehensive understanding of the association between the <italic>CYP2C9</italic> polymorphism and CRC.</p>
      <p>This meta-analysis is guided by the PRISMA statement (<xref ref-type="supplementary-material" rid="pone.0060607.s006">Checklist S1</xref>).</p>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pone.0060607.s001" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0060607.s001" position="float" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p>
            <bold>The association study selection process.</bold>
          </p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0060607.s002" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0060607.s002" position="float" xlink:type="simple">
        <label>Figure S2</label>
        <caption>
          <p>
            <bold>Result of sensitivity analyses for CYP2C9*2 carrier and CRC risk.</bold>
          </p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0060607.s003" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0060607.s003" position="float" xlink:type="simple">
        <label>Figure S3</label>
        <caption>
          <p>
            <bold>Result of sensitivity analyses for CYP2C9*3 carrier and CRC risk.</bold>
          </p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0060607.s004" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0060607.s004" position="float" xlink:type="simple">
        <label>Figure S4</label>
        <caption>
          <p>
            <bold>Funnel plot for the association between and CYP2C9 *2 carrier and colorectal cancer risk; Egger's test was also performed to investigate the symmetry of the funnel plot (</bold>
            <bold>
              <italic>P</italic>
            </bold>
            <bold> = 0.96).</bold>
          </p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0060607.s005" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0060607.s005" position="float" xlink:type="simple">
        <label>Figure S5</label>
        <caption>
          <p>
            <bold>Funnel plot for the association between and CYP2C9 *3 carrier and colorectal cancer risk; Egger's test was also performed to investigate the symmetry of the funnel plot (</bold>
            <bold>
              <italic>P</italic>
            </bold>
            <bold> = 0.95).</bold>
          </p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0060607.s006" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0060607.s006" position="float" xlink:type="simple">
        <label>Checklist S1</label>
        <caption>
          <p>
            <bold>PRISMA 2009 Checklist.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pone.0060607-Jemal1">
        <label>1</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Siegel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>E</given-names></name> (<year>2010</year>) <article-title>Cancer statistics, 2010</article-title>. <source>CA Cancer? J? Clin</source> <volume>60</volume>: <fpage>277</fpage>–<lpage>300</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Lichtenstein1">
        <label>2</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lichtenstein</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Holm</surname><given-names>NV</given-names></name>, <name name-style="western"><surname>Verkasalo</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Iliadou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kaprio</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland</article-title>. <source>N? Engl? J? Med</source> <volume>343</volume>: <fpage>78</fpage>–<lpage>85</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Calvert1">
        <label>3</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Calvert</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Frucht</surname><given-names>H</given-names></name> (<year>2002</year>) <article-title>The genetics of colorectal cancer</article-title>. <source>Ann Intern Med</source> <volume>137</volume>: <fpage>603</fpage>–<lpage>612</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Bartsch1">
        <label>4</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bartsch</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nair</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Owen</surname><given-names>RW</given-names></name> (<year>1999</year>) <article-title>Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers</article-title>. <source>Carcinogenesis</source> <volume>20</volume>: <fpage>2209</fpage>–<lpage>2218</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-deVerdier1">
        <label>5</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Verdier</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hagman</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Steineck</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Overvik</surname><given-names>E</given-names></name> (<year>1991</year>) <article-title>Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm</article-title>. <source>Int? J? Cancer</source> <volume>49</volume>: <fpage>520</fpage>–<lpage>525</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Nagao1">
        <label>6</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nagao</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sugimura</surname><given-names>T</given-names></name> (<year>1993</year>) <article-title>Carcinogenic factors in food with relevance to colon cancer development</article-title>. <source>Mutat Res</source> <volume>90</volume>: <fpage>43</fpage>–<lpage>51</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Sugimura1">
        <label>7</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sugimura</surname><given-names>T</given-names></name> (<year>2000</year>) <article-title>Nutrition and dietary carcinogens</article-title>. <source>Carcinogenesis</source> <volume>21</volume>: <fpage>387</fpage>–<lpage>395</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Schwarz1">
        <label>8</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schwarz</surname><given-names>UI</given-names></name> (<year>2003</year>) <article-title>Clinical relevance of genetic polymorphisms in the human CYP2C9 gene</article-title>. <source>Eur? J? Clin Invest</source> (Suppl 2)<fpage>23</fpage>–<lpage>30</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Gooderham1">
        <label>9</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gooderham</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Yadollahi-Farsani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Food-derived heterocyclic amine mutagens: variable metabolism and significance to humans</article-title>. <source>Drug Metab Dispos</source> <volume>29</volume>: <fpage>529</fpage>–<lpage>534</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Oda1">
        <label>10</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oda</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Aryal</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Terashita</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gillam</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Guengerich</surname><given-names>FP</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1 and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase</article-title>. <source>Mutat Res</source> <volume>492</volume>: <fpage>81</fpage>–<lpage>90</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-SullivanKlose1">
        <label>11</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sullivan-Klose</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Ghanayem</surname><given-names>BI</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>ZY</given-names></name>, <name name-style="western"><surname>Kaminsky</surname><given-names>LS</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>The role of the CYP2C9-Leu 359 allelic variant in the tolbutamide polymorphism</article-title>. <source>Pharmacogenetics</source> <volume>6</volume>: <fpage>341</fpage>–<lpage>349</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Gill1">
        <label>12</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gill</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Tjia</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Kitteringham</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Pirmohamed</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Back</surname><given-names>DJ</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation</article-title>. <source>Pharmacogenetics</source> <volume>9</volume>: <fpage>43</fpage>–<lpage>53</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Cochran1">
        <label>13</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cochran</surname><given-names>WG</given-names></name> (<year>1954</year>) <article-title>The combination of estimates from different experiments</article-title>. <source>Biometrics</source> <volume>10</volume>: <fpage>101</fpage>–<lpage>129</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Higgins1">
        <label>14</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Thompson1">
        <label>15</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>SJ</given-names></name> (<year>1999</year>) <article-title>Explaining heterogeneity in meta-analysis: a comparison of methods</article-title>. <source>Stat Med</source> <volume>18</volume>: <fpage>2693</fpage>–<lpage>2708</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Begg1">
        <label>16</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Egger1">
        <label>17</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>34</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Sainz1">
        <label>18</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sainz</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rudolph</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hein</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hoffmeister</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Buch</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk</article-title>. <source>Endocr Relat Cancer</source> <volume>18</volume>: <fpage>265</fpage>–<lpage>276</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Cleary1">
        <label>19</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cleary</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Cotterchio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gallinger</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>P</given-names></name> (<year>2010</year>) <article-title>Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk</article-title>. <source>Am? J? Epidemiol</source> <volume>172</volume>: <fpage>1000</fpage>–<lpage>1014</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Northwood1">
        <label>20</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Northwood</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Forman</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Barrett</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Wilkie</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk</article-title>. <source>Pharmacogenet Genomics</source> <volume>20</volume>: <fpage>315</fpage>–<lpage>326</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Buyukdogan1">
        <label>21</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Buyukdogan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Boruban</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Artac</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Demirel</surname><given-names>S</given-names></name> (<year>2009</year>) <article-title>Frequency of Cytochrome 450 (CYP2C9 and CYP2C19) Genetic Polimorphisms in Patients with Colorectal Carsinoma</article-title>. <source>International Journal of Hematology and Oncology</source> <volume>19</volume>: <fpage>134</fpage>–<lpage>139</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Cotterchio1">
        <label>22</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cotterchio</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Boucher</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Manno</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gallinger</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Okey</surname><given-names>AB</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>17</volume>: <fpage>3098</fpage>–<lpage>3107</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Liao1">
        <label>23</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liao</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>AK</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese</article-title>. <source>Clin Chim Acta</source> <volume>380</volume>: <fpage>191</fpage>–<lpage>196</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Kry1">
        <label>24</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Küry</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Buecher</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Robiou-du-Pont</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Scoul</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sébille</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>16</volume>: <fpage>1460</fpage>–<lpage>1467</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Samowitz1">
        <label>25</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Samowitz</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Curtin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>KN</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention</article-title>. <source>Clin Gastroenterol Hepatol</source> <volume>4</volume>: <fpage>894</fpage>–<lpage>901</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-McGreavey1">
        <label>26</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McGreavey</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Boylan</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Timothy Bishop</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma</article-title>. <source>Pharmacogenet Genomics</source> <volume>15</volume>: <fpage>713</fpage>–<lpage>721</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Tranah1">
        <label>27</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tranah</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Giovannucci</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study</article-title>. <source>Mol Carcinog</source> <volume>44</volume>: <fpage>21</fpage>–<lpage>30</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Landi1">
        <label>28</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gemignani</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Gioia-Patricola</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chabrier</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer</article-title>. <source>Pharmacogenet Genomics</source> <volume>15</volume>: <fpage>535</fpage>–<lpage>546</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Chan1">
        <label>29</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chan</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Tranah</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Giovannucci</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Fuchs</surname><given-names>CS</given-names></name> (<year>2004</year>) <article-title>A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma</article-title>. <source>Clin Gastroenterol Hepatol</source> <volume>2</volume>: <fpage>704</fpage>–<lpage>712</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Martnez1">
        <label>30</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martínez</surname><given-names>C</given-names></name>, <name name-style="western"><surname>García-Martín</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Ladero</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Sastre</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Garcia-Gamito</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk</article-title>. <source>Carcinogenesis</source> <volume>22</volume>: <fpage>1323</fpage>–<lpage>1326</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Risch1">
        <label>31</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Risch</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Merikangas</surname><given-names>K</given-names></name> (<year>1996</year>) <article-title>The future of genetic studies of complex human diseases</article-title>. <source>Science</source> <volume>273</volume>: <fpage>1516</fpage>–<lpage>1517</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Lee1">
        <label>32</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>CR</given-names></name> (<year>2004</year>) <article-title>CYP2C9 genotype as a predictor of drug disposition in humans</article-title>. <source>Methods Find Exp Clin Pharmacol</source> <volume>26</volume>: <fpage>463</fpage>–<lpage>472</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Shou1">
        <label>33</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Korzekwa</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Crespi</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>FJ</given-names></name>, <name name-style="western"><surname>Gelboin</surname><given-names>HV</given-names></name> (<year>1994</year>) <article-title>The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol</article-title>. <source>Mol Carcinog</source> <volume>10</volume>: <fpage>159</fpage>–<lpage>168</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Takahashi1">
        <label>34</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takahashi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Kashima</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nomoto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Iwade</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tainaka</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes</article-title>. <source>Pharmacogenetics</source> <volume>8</volume>: <fpage>365</fpage>–<lpage>373</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Baron1">
        <label>35</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baron</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Sandler</surname><given-names>RS</given-names></name> (<year>2000</year>) <article-title>Nonsteroidal anti-inflammatory drugs and cancer prevention</article-title>. <source>Annu Rev Med</source> <volume>51</volume>: <fpage>511</fpage>–<lpage>523</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0060607-Haining1">
        <label>36</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haining</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Veronese</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Trager</surname><given-names>WF</given-names></name>, <name name-style="western"><surname>Rettie</surname><given-names>AE</given-names></name> (<year>1996</year>) <article-title>Allelic variants of human cytochrome P450 2C9: baculovirus-mediated expression, purification, structural characterization, substrate stereoselectivity, and prochiral selectivity of the wild-type and I359L mutant forms</article-title>. <source>Arch Biochem Biophys</source> <volume>333</volume>: <fpage>447</fpage>–<lpage>558</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>